Global biotechnology leader CSL Behring and Australia’s deep tech incubator Cicada Innovations are launching an innovation challenge for scientists, researchers and rare disease patients. The mission: to brainstorm new ways to help meet growing worldwide demand for plasma-derived immunoglobulin.
Plasma is a natural, but limited, resource needed to make life-saving medicines for people who are living with rare diseases such as primary immunodeficiency. Organizers are casting a wide net, and also looking outside the plasma industry, to uncover fresh approaches to boost supply. Awards will include mentorship from a CSL Behring leader as well as a monetary prize.
Learn more about the challenge by attending the official kickoff.
When: 14 April in Asia Pacific /April 13 in North America and Europe
Where: Virtual – register here
Who: Open call to all innovators
Participants have until May 26 to submit their ideas.
